UBS Cuts BUD APAC (01876) Target Price to HK$8.75, Maintains "Buy" Rating

Stock News
10/31

UBS released a research report stating that BUD APAC (01876) reported Q3 2025 revenue and adjusted EBITDA of $1.555 billion and $438 million, respectively, down 8.8% and 8.6% year-on-year. These figures were 1-3% below the bank's expectations but broadly in line with market consensus.

The bank lowered its 2025–2027 earnings forecasts for BUD APAC by 7–9%, citing persistent weakness in the Chinese market and limited visibility for Q4, with recovery now expected to be delayed until 2026.

Despite the downward revision, UBS maintained a "Buy" rating, citing premiumization trends in the home consumption channel, attractive valuation, and strong cash reserves sufficient to support stable dividends in 2025. The target price was reduced from HK$9.07 to HK$8.75.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10